Glioblastoma

Showing NaN - NaN of 51

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Recurrent Glioblastoma, Resectable Glioblastoma Trial in Los Angeles (Biospecimen Collection, Magnetic Resonance

Recruiting
  • Glioblastoma
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

Recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Biopsy
  • +3 more
  • Birmingham, Alabama
  • +62 more
Feb 2, 2023

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Glioblastoma Trial in United States (Abemaciclib, Surgery)

Active, not recruiting
  • Glioblastoma
  • Los Angeles, California
  • +6 more
Dec 28, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Virtual group based physical activity (BurnAlong) and Social Media

Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 7, 2022

Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

Available
  • Pancreatic Cancer
  • +20 more
  • Ulixertinib (BVD-523)
  • Birmingham, Alabama
  • +25 more
Nov 4, 2022

Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • RSC-1255 Dose Escalation
  • RSC-1255 Dose Expansion
  • Los Angeles, California
  • +5 more
Oct 24, 2022

Glioblastoma Trial in Canada, China, United States (drug, other, radiation)

Active, not recruiting
  • Glioblastoma
  • Enzastaurin Hydrochloride
  • +3 more
  • Birmingham, Alabama
  • +62 more
Oct 11, 2022

Glioblastoma Trial in Australia, United States (drug, radiation, biological)

Completed
  • Glioblastoma
  • Los Angeles, California
  • +7 more
Oct 3, 2022

Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +6 more
  • Costa Mesa, California
  • +49 more
Aug 24, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier Trial in Worldwide (CC-122)

Active, not recruiting
  • Multiple Myeloma
  • +5 more
  • Duarte, California
  • +38 more
Aug 18, 2022

Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

Recruiting
  • Glioblastoma
  • +5 more
  • Ipilimumab
  • +4 more
  • Birmingham, Alabama
  • +19 more
Aug 16, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022

Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)

Recruiting
  • Glioblastoma
  • Adult-type Diffuse Gliomas
  • Beverly Hills, California
  • +83 more
Jul 25, 2022

Glioblastoma, Glioblastoma Multiforme Trial in United States (drug, other, radiation)

Recruiting
  • Glioblastoma
  • Glioblastoma Multiforme
  • Los Angeles, California
  • +3 more
May 31, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma, Diffuse Midline Glioma, H3 K27M Glioma Trial in United States (ONC201)

Active, not recruiting
  • Glioblastoma
  • +5 more
  • Los Angeles, California
  • +4 more
Apr 8, 2022

Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)

Active, not recruiting
  • Glioblastoma
  • Birmingham, Alabama
  • +60 more
Apr 4, 2022

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Los Angeles, San Diego (biological, drug, other, genetic)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • bevacizumab
  • +5 more
  • Los Angeles, California
  • +2 more
Feb 10, 2022

Glioblastoma Trial in Los Angeles (Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography)

Recruiting
  • Glioblastoma
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 2, 2022

Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)

Recruiting
  • Cancer
  • +22 more
  • Elly Mobile Phone Application
  • Los Angeles, California
    Cedars Sinai Medical Center
Dec 7, 2021

Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard

Completed
  • Glioblastoma
  • +4 more
  • Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
  • Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
  • Los Angeles, California
    Cedars-Sinai Medical Center
Nov 18, 2021